SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-067126
Filing Date
2018-03-01
Accepted
2018-03-01 16:08:06
Documents
3
Period of Report
2018-03-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d526498d8k.htm 8-K 14926
2 EX-99.1 d526498dex991.htm EX-99.1 115161
3 GRAPHIC g526498sp1.jpg GRAPHIC 3119
  Complete submission text file 0001193125-18-067126.txt   135912
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 18657307
SIC: 2834 Pharmaceutical Preparations